advertisement
 |
|
Top Stories
The companies announced the European launch of Imraldi (adalimumab), a biosimilar referencing AbbVie's blockbuster Humira (adalimumab).
/ read more /
The acquisition allows Lonza to further develop technology for scalable autologous cell-therapy manufacturing.
/ read more /
|
|
|
advertisement
 |
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers |
 |
|
|
advertisement
 |
|
Industry News
Research from Massachusetts Institute of Technology suggests that small chips could replace standard lab-scale spectrometry equipment for many applications.
/ read more /
The latest CPhI Worldwide survey results have revealed a promising outlook for the global pharma economies.
/ read more /
More Industry News
|
|
|
advertisement
 |
|
advertisement
 |
|
Supplier News
The investment in the company's Mississauga, Canada, laboratory includes an expansion of existing cell/tissue culture capabilities, flow cytometry, mass spectrometry facilities, and more.
/ read more /
The company has expanded its operations in the United States with the opening of a new 45,000-ft2, early-phase formulation and manufacturing facility located in Garnet Valley, PA.
/ read more /
More Supplier News
|
|
|
advertisement
 |
|
advertisement
 |
|
Bio/Pharma News
The company added a new EUR 63-million (US$72-million) packaging center at its manufacturing site in Darmstadt, Germany.
/ read more /
AbbVie will assume full development and commercial responsibility for its collaboration with Galapagos to discover and develop new therapies to treat cystic fibrosis (CF).
/ read more /
More Bio/Pharma News
|
|
|
advertisement
 |
|
Regulatory News
The agency has approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza.
/ read more /
|
|
|
|
|
OUTSOURCING
Industry experts discuss the formulation and development issues that should be considered when addressing scale up from small-scale batches to commercial production.
/ read more /
|
|
|
|
QUALITY SYSTEMS
Internal release limits help ensure that a batch of drug product remains within specifications throughout its shelf life. This article explores what internal release limits are and why they are important.
/ read more /
|
|
|
Product Profile
 |
Agilent Provides Microparticles for High-Performance IVD Assays
Agilent provides magnetic and nonmagnetic beads tailored to the needs of manufacturers of in-vitro diagnostic (IVD) assays.
/ Read more/
|
|
|
|
Events
November 1–2, 2018
November 4–7, 2018
November 28–29, 2018
more events |
|
|
AAPS PharmSci 360 Exhibitor Preview
 |
Mikart specializes in the development, manufacturing, and packaging of solid-dose and liquid-oral dose products.
/ Read more/
|
 |
Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world.
/ Read more/
|
 |
Thermo Fisher Scientific's Patheon and Fisher Clinical Services brands provide industry-leading solutions for drug development, clinical trial logistics, and commercial manufacturing to customers of all sizes.
/ Read more/
|
 |
USP is a scientific, nonprofit organization that sets standards for quality medicines. USP standards are the industry benchmark because of the robust scientific process used in their development.
/ Read more/
|
|
|
New Products and Services
 |
VAI's manufacturing and testing operations mirror current GMP/GLP standards. Our products and services include a comprehensive line of disinfectants, sporicides, consulting, and more.
/ Read more/
|
|
|
|
eBOOKS
 |
This ebook covers novel technologies for the formulation, manufacture, purification, and delivery of sterile small- and large-molecule drugs, including single-use systems, facilities and equipment, contamination issues, and process analytics. |
|
|
|
|
|
